| First Author | Wesslau KP | Year | 2019 |
| Journal | Int J Mol Sci | Volume | 20 |
| Issue | 9 | PubMed ID | 31075901 |
| Mgi Jnum | J:289680 | Mgi Id | MGI:6434585 |
| Doi | 10.3390/ijms20092298 | Citation | Wesslau KP, et al. (2019) P2X7 Receptor Indirectly Regulates the JAM-A Protein Content via Modulation of GSK-3beta. Int J Mol Sci 20(9):2298 |
| abstractText | The alveolar epithelial cells represent an important part of the alveolar barrier, which is maintained by tight junction proteins, particularly JAM-A, occludin, and claudin-18, which regulate paracellular permeability. In this study, we report on a strong increase in epithelial JAM-A expression in P2X7 receptor knockout mice when compared to the wildtype. Precision-cut lung slices of wildtype and knockout lungs and immortal epithelial lung E10 cells were treated with bleomycin, the P2X7 receptor inhibitor oxATP, and the agonist BzATP, respectively, to evaluate early changes in JAM-A expression. Biochemical and immunohistochemical data showed evidence for P2X7 receptor-dependent JAM-A expression in vitro. Inhibition of the P2X7 receptor using oxATP increased JAM-A, whereas activation of the receptor decreased the JAM-A protein level. In order to examine the role of GSK-3beta in the expression of JAM-A in alveolar epithelial cells, we used lithium chloride for GSK-3beta inhibiting experiments, which showed a modulating effect on bleomycin-induced alterations in JAM-A levels. Our data suggest that an increased constitutive JAM-A protein level in P2X7 receptor knockout mice may have a protective effect against bleomycin-induced lung injury. Bleomycin-treated precision-cut lung slices from P2X7 receptor knockout mice responded with a lower increase in mRNA expression of JAM-A than bleomycin-treated precision-cut lung slices from wildtype mice. |
